K.J. Harrison & Partners Inc Takes $1.86 Million Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

K.J. Harrison & Partners Inc acquired a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the fourth quarter, Holdings Channel.com reports. The fund acquired 20,812 shares of the exchange traded fund’s stock, valued at approximately $1,858,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Migdal Insurance & Financial Holdings Ltd. acquired a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at $102,900,000. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in shares of SPDR S&P Biotech ETF by 103.3% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,771,000 shares of the exchange traded fund’s stock worth $129,318,000 after acquiring an additional 900,000 shares in the last quarter. Employees Retirement System of Texas acquired a new stake in SPDR S&P Biotech ETF during the third quarter valued at $27,456,000. MBB Public Markets I LLC grew its stake in SPDR S&P Biotech ETF by 67.0% in the third quarter. MBB Public Markets I LLC now owns 514,411 shares of the exchange traded fund’s stock valued at $37,562,000 after purchasing an additional 206,337 shares in the last quarter. Finally, abrdn plc acquired a new position in SPDR S&P Biotech ETF in the 4th quarter worth about $14,436,000.

SPDR S&P Biotech ETF Stock Up 1.5 %

Shares of XBI traded up $1.27 during midday trading on Friday, reaching $83.49. 10,390,133 shares of the stock were exchanged, compared to its average volume of 11,723,970. The company has a market cap of $6.49 billion, a price-to-earnings ratio of 11.47 and a beta of 1.08. SPDR S&P Biotech ETF has a 12-month low of $63.80 and a 12-month high of $103.52. The firm has a 50 day simple moving average of $92.69 and a 200-day simple moving average of $84.64.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.